Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment.
about
Recent Nanotechnology Approaches for Prevention and Treatment of Biofilm-Associated Infections on Medical DevicesSilver and Alginates: Role in Wound Healing and Biofilm ControlNext science wound gel technology, a novel agent that inhibits biofilm development by gram-positive and gram-negative wound pathogensSilver as an antimicrobial: facts and gaps in knowledge.Gum arabic capped-silver nanoparticles inhibit biofilm formation by multi-drug resistant strains of Pseudomonas aeruginosa.Development and application of a polymicrobial, in vitro, wound biofilm model.Silver nanoparticles: correlating nanoparticle size and cellular uptake with genotoxicity.Two-Phase Bactericidal Mechanism of Silver Nanoparticles against Burkholderia pseudomallei.Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges.Clinical investigation of biofilm in non-healing wounds by high resolution microscopy techniques.Novel therapeutic strategies to counter Pseudomonas aeruginosa infections.A review of the scientific evidence for biofilms in wounds.Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review.Antiseptics for treating infected wounds: Efficacy on biofilms and effect of pH.Managing biofilm by using dressings.Antifouling and antimicrobial biomaterials: an overview.Manuka honey inhibits adhesion and invasion of medically important wound bacteria in vitro.Nanosilver-Silica Composite: Prolonged Antibacterial Effects and Bacterial Interaction Mechanisms for Wound Dressings.Biofilms and delayed healing - an in vitro evaluation of silver- and iodine-containing dressings and their effect on bacterial and human cells.The efficacy of different anti-microbial metals at preventing the formation of, and eradicating bacterial biofilms of pathogenic indicator strains.In Vitro Assessment of the Antibacterial Potential of Silver Nano-Coatings on Cotton Gauzes for Prevention of Wound Infections.Killing bacteria within biofilms by sustained release of tetracycline from triple-layered electrospun micro/nanofibre matrices of polycaprolactone and poly(ethylene-co-vinyl acetate).Usnic acid, a lichen secondary metabolite inhibits Group A Streptococcus biofilms.Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms.Optimization and integration of nanosilver on polycaprolactone nanofibrous mesh for bacterial inhibition and wound healing in vitro and in vivo.Growth of MRSA and Pseudomonas aeruginosa in a fine-celled foam model containing sessile commensal skin bacteria.Early use of negative pressure therapy in combination with silver dressings in a difficult breast abscess.A comparison of the antimicrobial efficacy of two silver-containing wound dressings on burn wound isolates.Biofilm inhibitory and eradicating activity of wound care products against Staphylococcus aureus and Staphylococcus epidermidis biofilms in an in vitro chronic wound model.Silver oxynitrate - an efficacious compound for the prevention and eradication of dual-species biofilms.Evidence for silver in wound care - meta-analysis of clinical studies from 2000-2015.Appropriate use of silver dressings in wounds: international consensus document.Magnetic fields suppressPseudomonas aeruginosabiofilms and enhance ciprofloxacin activity
P2860
Q28074875-9DA121FC-EBCD-4973-B775-F42D469283D5Q28081800-353D794E-5B8C-4A2F-834D-9711D160AF49Q33797914-0FB39807-CE52-4DD6-8E97-787BF8559757Q34296453-39D1CA2A-38A2-47B2-9669-6672EB9AAD34Q35084741-645E5B8E-067A-438D-B53E-657DE3426892Q35884125-47B1881A-DC17-430F-A72B-917F4E9CFD2EQ36049409-0A8E9FBC-727E-448E-B87C-CEA6317F9E9EQ36224990-7809D083-79E9-46C2-9979-93AB95B5CA0CQ37080475-A2C3744A-CEAE-4181-8EA2-449E2873EDD8Q37326974-0832D797-F279-4149-85F8-A6402108F2C5Q37984505-AA4ACA64-60B8-4B83-AA10-B898D54E2172Q38044030-28387147-82FD-4AF1-8335-B29611A25F0DQ38077408-8EA8541B-73B1-45B3-BA3C-24C3416AC11CQ38243476-D7CBE832-4042-494E-9DE7-4371726481F1Q38520121-2120E377-27C2-4E92-97E5-7563A13BF4AAQ39240773-7ED5CDD5-E011-4E9F-A544-0FC0F026CC75Q39309718-6A6E1A47-B821-41E0-B629-ABAA56B2E2B7Q40054884-5A232CEB-2CDD-4CFC-AA85-52C906ED89AAQ40213188-1FF36D14-02AC-4D0C-81AF-ABA8C1F46B46Q40333304-8CCB5147-F2CF-4D7C-9382-1BB24794BBD7Q40663336-F14033D6-74F2-45FD-BC84-93C9E86A2C3AQ41197697-2F5CAC21-675A-42AC-B579-B57C30638173Q41678717-16627247-3CE5-40E6-845A-D2F867DA5538Q41819155-3C6BE603-2F83-4F6F-A440-8D8E831D3F65Q41848710-9B912FF4-025E-48C7-B8CA-A50B837F2D6DQ41852715-C18814CF-2E6C-4470-869F-87522C65E8B0Q43757467-90CE8145-DF28-4469-9B6B-84E4ABD3E667Q44972230-A9A9E303-805E-49B2-88CB-F3115DF0DC02Q45889513-907F8275-A3F6-4571-B64C-99923DE03F8FQ46363943-22C2EEDE-3DC2-4BE0-BE17-0FA015708E4CQ47853498-20835237-0E6A-4118-B9FE-689E7A426D5AQ53123451-5F45DF87-D266-4750-B6B5-815C5BF91F09Q57378228-525047AD-D396-4806-AACF-6ECCCC42AB75
P2860
Impact of silver-containing wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Impact of silver-containing wo ...... cs during prolonged treatment.
@ast
Impact of silver-containing wo ...... cs during prolonged treatment.
@en
Impact of silver-containing wo ...... cs during prolonged treatment.
@nl
type
label
Impact of silver-containing wo ...... cs during prolonged treatment.
@ast
Impact of silver-containing wo ...... cs during prolonged treatment.
@en
Impact of silver-containing wo ...... cs during prolonged treatment.
@nl
prefLabel
Impact of silver-containing wo ...... cs during prolonged treatment.
@ast
Impact of silver-containing wo ...... cs during prolonged treatment.
@en
Impact of silver-containing wo ...... cs during prolonged treatment.
@nl
P2093
P2860
P356
P1476
Impact of silver-containing wo ...... cs during prolonged treatment.
@en
P2093
Jeffrey Lyczak
Katherine Turner
Robert John Martinuzzi
Victoria Kostenko
P2860
P304
P356
10.1128/AAC.00825-10
P407
P577
2010-09-20T00:00:00Z